Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.
about
Bimatoprost in the treatment of eyelash hypotrichosisCannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cellsLipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells.Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides.Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species.Revisiting CB1 receptor as drug target in human melanoma.Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels.
P2860
Q33819865-C081E043-F542-499E-AF48-346391F14755Q34338079-50B4F81E-F5BE-4572-A3E3-637B27CD93AAQ36947747-024DA81F-6068-4B35-A7A0-0A3D1AD0FE5EQ37219066-CCCC3798-9C30-4C21-BE4D-8E53AC7EB1F2Q37223268-B182BA8F-4047-4138-BCDE-807A0ABC542AQ37588464-055F8DDA-75EE-4083-B198-3C9CDE5C4F2FQ37644978-67F57414-0B88-483A-8C5C-F03B689C42B7Q37805184-76D3F0A3-0675-4AA2-8C64-E9502FD6931AQ38889500-832EA4B7-E1A5-4855-BEDA-EFAC2D99FD0CQ38923372-B4F31866-68D5-497B-A96C-FDD49C7C4283Q38998420-9991713B-06B3-4E0D-8AC0-1726B1C86FACQ39374200-31E86CAF-DA50-4C97-A82B-664C9C33512BQ41785702-7F81C136-8798-4A8A-B96B-E7F9018E75BC
P2860
Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Changes in the endocannabinoid ...... fective treatments for cancer.
@en
Changes in the endocannabinoid ...... fective treatments for cancer.
@nl
type
label
Changes in the endocannabinoid ...... fective treatments for cancer.
@en
Changes in the endocannabinoid ...... fective treatments for cancer.
@nl
prefLabel
Changes in the endocannabinoid ...... fective treatments for cancer.
@en
Changes in the endocannabinoid ...... fective treatments for cancer.
@nl
P2860
P1476
Changes in the endocannabinoid ...... fective treatments for cancer.
@en
P2093
Gianfranco Alpini
Sharon Demorrow
P2860
P304
P356
10.1016/S0083-6729(09)81018-2
P577
2009-01-01T00:00:00Z